Hypothesis

Senescent microglia in aged white matter release extracellular vesicles (EVs) enriched with mitochondrial DNA and associated damage‑associated molecular patterns (mt‑DAMPs). These EVs are taken up by nearby oligodendrocyte precursor cells (OPCs), triggering a maladaptive response that impairs differentiation and promotes ectopic lipid accumulation, thereby accelerating myelin loss independent of classical inflammatory cytokine signaling.

Mechanistic Rationale

• Wang et al. (2025) demonstrated pronounced upregulation of microglial markers LGALS3 and TREM2 in fiber tracts, accompanied by microglial nodular formations opposed to degraded myelin (https://pmc.ncbi.nlm.nih.gov/articles/PMC11971433/).
• Senescent cells are known to shed EVs that carry nucleic acids, proteins, and lipids capable of altering recipient cell phenotype (https://pmc.ncbi.nlm.nih.gov/articles/PMC7749315/).
• Mitochondrial DNA released from damaged microglia can act as a potent DAMP, activating cytosolic DNA sensing pathways (cGAS‑STING) in OPCs, leading to type‑I interferon–like responses that block myelination programs (https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2022.1090109/full).
• The spatial restriction of these changes to white matter suggests a paracrine loop where senescent microglia locally shape the oligodendroglial niche.

Testable Predictions

1. EV Isolation: EVs purified from white matter of aged mice (11 vs. 126 weeks) will contain higher levels of mitochondrial DNA and mt‑DAMPs compared to young tissue.
2. OPC Uptake: Fluorescently labeled EVs from aged microglia will be preferentially internalized by PDGFRα⁺ OPCs situated within 50 µm of LGALS3⁺ microglial nodules in situ.
3. Functional Consequence: OPCs exposed to aged‑microglia EVs in vitro will show reduced expression of myelin genes (Mbp, Plp1) and increased lipid droplet formation, effects blocked by mt‑DNA scavengers or cGAS‑STING inhibition.
4. In Vivo Rescue: Genetic ablation of EV release from microglia (using Cx3cr1‑CreER; Rab27a^fl/fl) in aged mice will preserve OPC differentiation and mitigate myelin loss measured by MBP immunostaining and MRI‑derived RTOP metrics.
5. Human Correlate: Post‑mortem human white matter with elevated LGALS3+ microglia will show increased mt‑DNA immunoreactivity within Olig2⁺ cells.

Experimental Approach

• Spatial Validation: Perform sequential immunofluorescence for LGALS3, mt‑DNA (using anti‑mt‑DNA antibody), and Olig2 on coronal sections; quantify colocalization at sub‑spot resolution using high‑plex imaging (e.g., CODEX or MERFISH) to overcome Visium’s 55 µm limitation (https://pmc.ncbi.nlm.nih.gov/articles/PMC12298044/).
• EV Profiling: Isolate EVs via differential ultracentrifugation from microdissected corpus callosum; assess mt‑DNA copy number by qPCR and proteomic cargo via LC‑MS/MS.
• Functional Assays: Culture primary OPCs from neonatal mice; treat with EVs; measure differentiation (MBP immunostaining), lipid accumulation (BODIPY), and signaling (phospho‑STING, IRF3).
• In Vivo Intervention: Induce tamoxifen‑mediated Rab27a knockout in microglia at 11 weeks; monitor myelin integrity at 57 and 126 weeks via MRI and histology.

Potential Confounds and Controls

• Ensure that observed effects are not secondary to increased proinflammatory cytokines; include cytokine‑blocking antibodies (anti‑IL‑1β, anti‑TNFα) in vitro to isolate mt‑DNA contribution.
• Verify that Rab27a deletion does not alter microglial survival or proliferation (Iba1 cell counts).
• Use age‑matched wild‑type littermates as controls for all experiments.

If validated, this hypothesis would reposition mitochondrial DAMPs carried by microglia‑derived EVs as a primary driver of age‑associated white matter deterioration, shifting focus from broad inflammatory senescence to specific organelle‑targeted paracrine signaling.